BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Principi N, Esposito S. Prevention of Community-Acquired Pneumonia with Available Pneumococcal Vaccines. Int J Mol Sci 2016;18:E30. [PMID: 28029140 DOI: 10.3390/ijms18010030] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 2.7] [Reference Citation Analysis]
Number Citing Articles
1 Principi N, Esposito A, Giannitto C, Esposito S. Lung ultrasonography to diagnose community-acquired pneumonia in children. BMC Pulm Med 2017;17:212. [PMID: 29258484 DOI: 10.1186/s12890-017-0561-9] [Cited by in Crossref: 12] [Cited by in F6Publishing: 7] [Article Influence: 2.4] [Reference Citation Analysis]
2 Smith AM, Huber VC. The Unexpected Impact of Vaccines on Secondary Bacterial Infections Following Influenza. Viral Immunol 2018;31:159-73. [PMID: 29148920 DOI: 10.1089/vim.2017.0138] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 2.2] [Reference Citation Analysis]
3 Doran SJ, Henry RJ, Shirey KA, Barrett JP, Ritzel RM, Lai W, Blanco JC, Faden AI, Vogel SN, Loane DJ. Early or Late Bacterial Lung Infection Increases Mortality After Traumatic Brain Injury in Male Mice and Chronically Impairs Monocyte Innate Immune Function. Crit Care Med 2020;48:e418-28. [PMID: 32149839 DOI: 10.1097/CCM.0000000000004273] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 9.0] [Reference Citation Analysis]
4 Wiese AD, Griffin MR, Grijalva CG. Impact of pneumococcal conjugate vaccines on hospitalizations for pneumonia in the United States. Expert Rev Vaccines 2019;18:327-41. [PMID: 30759352 DOI: 10.1080/14760584.2019.1582337] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 5.0] [Reference Citation Analysis]
5 Principi N, Esposito S. Emerging problems in the treatment of pediatric community-acquired pneumonia. Expert Rev Respir Med 2018;12:595-603. [PMID: 29883232 DOI: 10.1080/17476348.2018.1486710] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
6 Budden KF, Shukla SD, Rehman SF, Bowerman KL, Keely S, Hugenholtz P, Armstrong-James DPH, Adcock IM, Chotirmall SH, Chung KF, Hansbro PM. Functional effects of the microbiota in chronic respiratory disease. Lancet Respir Med 2019;7:907-20. [PMID: 30975495 DOI: 10.1016/S2213-2600(18)30510-1] [Cited by in Crossref: 77] [Cited by in F6Publishing: 49] [Article Influence: 25.7] [Reference Citation Analysis]
7 Hadfield J, Bennett L. Determining best outcomes from community-acquired pneumonia and how to achieve them. Respirology 2018;23:138-47. [PMID: 29150897 DOI: 10.1111/resp.13218] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 3.0] [Reference Citation Analysis]
8 Chuchalin AG, Onishchenko GG, Kolosov VP, Kurganova OP, Zaitseva TA, Manakov LG, Kholodok GN, Perelman JM, Kozlov RS, Ivakhnishina NM, Trotsenko OE, Bondarenko AP. Vaccine Prophylaxis of Pneumococcal Infections in Children under Conditions of Severe Flood in the Amur River Basin. Interdiscip Perspect Infect Dis 2019;2019:5467275. [PMID: 30906320 DOI: 10.1155/2019/5467275] [Reference Citation Analysis]
9 Bianchini S, Argentiero A, Camilloni B, Silvestri E, Alunno A, Esposito S. Vaccination against Paediatric Respiratory Pathogens. Vaccines (Basel) 2019;7:E168. [PMID: 31683882 DOI: 10.3390/vaccines7040168] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
10 Masomian M, Ahmad Z, Gew LT, Poh CL. Development of Next Generation Streptococcus pneumoniae Vaccines Conferring Broad Protection. Vaccines (Basel) 2020;8:E132. [PMID: 32192117 DOI: 10.3390/vaccines8010132] [Cited by in Crossref: 22] [Cited by in F6Publishing: 19] [Article Influence: 11.0] [Reference Citation Analysis]
11 Wójcik-Bojek U, Różalska B, Sadowska B. Staphylococcus aureus-A Known Opponent against Host Defense Mechanisms and Vaccine Development-Do We Still Have a Chance to Win? Int J Mol Sci 2022;23:948. [PMID: 35055134 DOI: 10.3390/ijms23020948] [Reference Citation Analysis]
12 Allin E, Nama N, Irvine MA, Pawliuk C, Wright M, Carwana M. Conservative and surgical modalities in the management of paediatric parapneumonic effusion and empyema: a protocol for a living systematic review and network meta-analysis. BMJ Open 2021;11:e045010. [PMID: 33762243 DOI: 10.1136/bmjopen-2020-045010] [Reference Citation Analysis]
13 Liang Z, Fu J, Li L, Yi R, Xu S, Chen J, Ye X, McGrath E. Molecular epidemiology of Streptococcus pneumoniae isolated from pediatric community-acquired pneumonia in pre-conjugate vaccine era in Western China. Ann Clin Microbiol Antimicrob 2021;20:4. [PMID: 33407509 DOI: 10.1186/s12941-020-00410-x] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
14 Esposito S, Dal Canto G, Caramia MR, Fainardi V, Pisi G, Principi N. Complications in community acquired pneumonia: magnitude of problem, risk factors, and management in pediatric age. Expert Rev Anti Infect Ther 2021;:1-7. [PMID: 33971782 DOI: 10.1080/14787210.2021.1927710] [Reference Citation Analysis]
15 Ruiz García Y, Nieto Guevara J, Izurieta P, Vojtek I, Ortega-Barría E, Guzman-Holst A. CIRCULATING CLONAL COMPLEXES AND SEQUENCE TYPES OF STREPTOCOCCUS PNEUMONIAE SEROTYPE 19A WORLDWIDE: THE IMPORTANCE OF MULTIDRUG RESISTANCE: A SYSTEMATIC LITERATURE REVIEW. Expert Rev Vaccines 2021;20:45-57. [PMID: 33507135 DOI: 10.1080/14760584.2021.1873136] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
16 Esposito S, Principi N. Defining the aetiology of paediatric community-acquired pneumonia: an unsolved problem. Expert Review of Respiratory Medicine 2019;13:153-61. [DOI: 10.1080/17476348.2019.1562341] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 2.7] [Reference Citation Analysis]